Update: 12.04.2021
Last week: 13 week 2022 (28.03.2022 - 03.04.2022)
Last full month: Mar 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | |||||||||
| WoW | 2 150 | -17.1% | 52.9% | -0.1 | 1 055 192 | -15.9% | 80.9% | 0.1 | -16.9% |
| MoM | 13 483 | 16.5% | 57.7% | 2 | 6 640 627 | 27.6% | 84.2% | 1.5 | 12.4% |
| YTD | 35 642 | 8.2% | 55.3% | -3.9 | 16 539 654 | 39.5% | 82.6% | 0.9 | 15.8% |
| MAT | 120 318 | -17.3% | 54.6% | -6.9 | 50 293 170 | 9.9% | 80.6% | -0.7 | -6.9% |
| KAPSIKAM | |||||||||
| WoW | 18 411 | -13.9% | 3.4% | 0 | 8 101 281 | -13.8% | 3.4% | 0 | -13.0% |
| MoM | 214 582 | 16.2% | 3.3% | -0.4 | 93 677 570 | 23.7% | 3.1% | -0.7 | 31.7% |
| YTD | 300 072 | -4.2% | 3.5% | -0.2 | 126 106 539 | -4.1% | 3.5% | -0.8 | 0.8% |
| MAT | 1 052 090 | -17.1% | 3.3% | -0.4 | 433 558 212 | -10.3% | 3.5% | -0.6 | -7.7% |
| MILDRONATE | |||||||||
| WoW | 102 457 | -12.0% | 23.3% | 1.7 | 67 355 172 | -11.6% | 24.3% | 2.1 | -18.3% |
| MoM | 669 749 | 31.6% | 22.6% | 0.7 | 423 078 923 | 74.3% | 23.0% | 2.4 | 27.2% |
| YTD | 1 632 749 | 31.0% | 16.8% | 2.2 | 861 761 374 | 63.3% | 17.4% | 3.5 | 13.7% |
| MAT | 5 182 414 | 15.8% | 17.1% | 2.5 | 2 267 716 418 | 26.8% | 15.7% | 2.4 | -0.9% |
| SULFARGIN | |||||||||
| WoW | 2 648 | -11.0% | 0.8% | 0.1 | 1 349 865 | -12.2% | 1.0% | 0.1 | -18.2% |
| MoM | 15 388 | 9.5% | 0.7% | -0.2 | 7 818 533 | 15.7% | 0.9% | -0.5 | 46.0% |
| YTD | 43 470 | 8.8% | 0.8% | 0.1 | 21 462 871 | 14.6% | 1.1% | 0.1 | 1.5% |
| MAT | 167 657 | -15.9% | 0.8% | -0.1 | 82 493 514 | -4.6% | 1.2% | 0 | -5.5% |
| VIPROSAL | |||||||||
| WoW | 23 786 | -16.5% | 4.0% | -0.2 | 10 294 070 | -16.2% | 4.0% | -0.1 | -13.1% |
| MoM | 152 058 | 24.2% | 4.3% | -0.2 | 65 689 053 | 35.4% | 4.1% | -0.4 | 30.8% |
| YTD | 399 327 | 37.4% | 4.4% | 1.1 | 163 727 366 | 46.5% | 4.3% | 0.8 | 1.9% |
| MAT | 1 352 158 | 1.0% | 4.0% | 0.3 | 523 263 598 | 8.5% | 4.0% | 0.1 | -7.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 35 642 | 8.2% | 55.3% | -3.9 | 16 539 654 | 39.5% | 82.6% | 0.9 | 15.8% |
| KAPSIKAM | 300 072 | -4.2% | 3.5% | -0.2 | 126 106 539 | -4.1% | 3.5% | -0.8 | 0.8% |
| MILDRONATE | 1 632 749 | 31.0% | 16.8% | 2.2 | 861 761 374 | 63.3% | 17.4% | 3.5 | 13.7% |
| SULFARGIN | 43 470 | 8.8% | 0.8% | 0.1 | 21 462 871 | 14.6% | 1.1% | 0.1 | 1.5% |
| VIPROSAL | 399 327 | 37.4% | 4.4% | 1.1 | 163 727 366 | 46.5% | 4.3% | 0.8 | 1.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 120 318 | -17.3% | 54.6% | -6.9 | 50 293 170 | 9.9% | 80.6% | -0.7 | -6.9% |
| KAPSIKAM | 1 052 090 | -17.1% | 3.3% | -0.4 | 433 558 212 | -10.3% | 3.5% | -0.6 | -7.7% |
| MILDRONATE | 5 182 414 | 15.8% | 17.1% | 2.5 | 2 267 716 418 | 26.8% | 15.7% | 2.4 | -0.9% |
| SULFARGIN | 167 657 | -15.9% | 0.8% | -0.1 | 82 493 514 | -4.6% | 1.2% | 0 | -5.5% |
| VIPROSAL | 1 352 158 | 1.0% | 4.0% | 0.3 | 523 263 598 | 8.5% | 4.0% | 0.1 | -7.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 2 150 | -17.1% | 52.9% | -0.1 | 1 055 192 | -15.9% | 80.9% | 0.1 | -16.9% |
| KAPSIKAM | 18 411 | -13.9% | 3.4% | 0 | 8 101 281 | -13.8% | 3.4% | 0 | -13.0% |
| MILDRONATE | 102 457 | -12.0% | 23.3% | 1.7 | 67 355 172 | -11.6% | 24.3% | 2.1 | -18.3% |
| SULFARGIN | 2 648 | -11.0% | 0.8% | 0.1 | 1 349 865 | -12.2% | 1.0% | 0.1 | -18.2% |
| VIPROSAL | 23 786 | -16.5% | 4.0% | -0.2 | 10 294 070 | -16.2% | 4.0% | -0.1 | -13.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 13 483 | 16.5% | 57.7% | 2 | 6 640 627 | 27.6% | 84.2% | 1.5 | 12.4% |
| KAPSIKAM | 214 582 | 16.2% | 3.3% | -0.4 | 93 677 570 | 23.7% | 3.1% | -0.7 | 31.7% |
| MILDRONATE | 669 749 | 31.6% | 22.6% | 0.7 | 423 078 923 | 74.3% | 23.0% | 2.4 | 27.2% |
| SULFARGIN | 15 388 | 9.5% | 0.7% | -0.2 | 7 818 533 | 15.7% | 0.9% | -0.5 | 46.0% |
| VIPROSAL | 152 058 | 24.2% | 4.3% | -0.2 | 65 689 053 | 35.4% | 4.1% | -0.4 | 30.8% |
Abbreviations
WoW - Week Over Week Change = Sales of the last week / Sales of the previous week - 1
MoM - Month Over Month Change = Sales of the last full month / Sales of the previous full month - 1
YTD - Year to Date - a period of time beginning the first day of the current calendar year up to the current date
MAT - Moving Annual Total - a period, being any 12 month period ending on the last week
MS - Market Share
Data Sources:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs